These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia. Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167 [TBL] [Abstract][Full Text] [Related]
5. [Chronic myeloid leukemia: a decade of progress]. Cervantes F Med Clin (Barc); 1990 Jan; 94(1):27-35. PubMed ID: 1692385 [No Abstract] [Full Text] [Related]
6. Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen. Takami A; Chuhjo T; Nakao S Haematologica; 2002 Jun; 87(6):659-61. PubMed ID: 12031925 [No Abstract] [Full Text] [Related]
7. [Interferon and chronic myeloid leukemia]. Steegmann JL; Pérez Sánchez M; Fernández-Rañada JM Sangre (Barc); 1990 Jun; 35(3):213-7. PubMed ID: 2204124 [No Abstract] [Full Text] [Related]
8. IL-2 in the treatment of chronic myeloid leukemia after lymphoid blast crisis: a pilot study. Meloni G; Foà R; Tosti S; Vignetti M; Gavosto F; Mandelli F Haematologica; 1990; 75(6):502-5. PubMed ID: 2098290 [TBL] [Abstract][Full Text] [Related]
9. Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis. Derderian PM; Kantarjian HM; Talpaz M; O'Brien S; Cork A; Estey E; Pierce S; Keating M Am J Med; 1993 Jan; 94(1):69-74. PubMed ID: 8420302 [TBL] [Abstract][Full Text] [Related]
10. [Chronic myeloid leukemia: progress and prospects]. Baccarani M; Russo D; Fanin R Haematologica; 1991 Jun; 76 Suppl 3():40-5. PubMed ID: 1752539 [No Abstract] [Full Text] [Related]
11. [Complete cytogenetic response obtained with unrelated donor lymphocyte infusion for relapse of chronic myeloid leukemia in blastic crisis after allogeneic bone marrow transplantation]. Fujimaki K; Maruta A; Yoshida M; Yamazaki E; Matsuzaki M; Fujisawa S; Kanamori H; Ishigatsubo Y Rinsho Ketsueki; 2001 Mar; 42(3):204-8. PubMed ID: 11345783 [TBL] [Abstract][Full Text] [Related]
12. Treatment of chronic granulocytic leukemia in blastic crisis. Canellos GP Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():131-2. PubMed ID: 2565744 [No Abstract] [Full Text] [Related]
13. Donor buffy-coat infusion and chemotherapy for leukemia in relapse after marrow transplantation. Bogdanić V; Aurer I; Hitrec V; Boban D; Nemet D; Zupancić-Salek S; Labar B Haematologica; 1995; 80(4):338-40. PubMed ID: 7590504 [TBL] [Abstract][Full Text] [Related]
15. Lymphoid blast crisis of chronic myelogenous leukemia occurring more than 11 years after receiving an allogeneic bone marrow transplant for chronic myelogenous leukemia in myeloid blast crisis at onset. Fukuno K; Tsurumi H; Yamada T; Oyama M; Matsuyama T; Terakura S; Kodera Y; Moriwaki H Bone Marrow Transplant; 2003 Feb; 31(3):211-3. PubMed ID: 12621483 [TBL] [Abstract][Full Text] [Related]
16. [Allogeneic bone marrow transplantation in myeloid leukemia: chemical conditioning, clinical course and results]. Glejzer O; Sedzimirska M; Tomaszewska-Toporska B; Tomeczko J; Kołodziej J; Pacuszko T; Was A; Bocheńska J; Jaźwiec B; Klimczak A Acta Haematol Pol; 1992; 23(2 Suppl 1):49-59. PubMed ID: 1488872 [TBL] [Abstract][Full Text] [Related]
17. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis. Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208 [TBL] [Abstract][Full Text] [Related]